| Angela D Price, APRN-C | |
|
1301 W 12th Ave, Emporia, KS 66801-2587 | |
| (620) 343-2900 | |
| Not Available |
| Full Name | Angela D Price |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1301 W 12th Ave, Emporia, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316485444 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newman Regional Health | Emporia, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
News outlets report that the outcome of some states' gubernatorial races will likely change the outlook for the health overhaul's sweeping Medicaid expansion. In general, however, the future remains unsettled.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency for the EPA's ToxCast screening program.
Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition of the journal Mucosal Immunology from the Nature Publishing Group.
They've seen horrors, experienced constant threats and survived traumatic events. Canada's military personnel often come back home with memories they'd rather forget. It's not scientifically understood why some soldiers develop post-traumatic stress disorder (PTSD) while others don't. However, many veterans simply don't ask for psychological help.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 1 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
News outlets report that the outcome of some states' gubernatorial races will likely change the outlook for the health overhaul's sweeping Medicaid expansion. In general, however, the future remains unsettled.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency for the EPA's ToxCast screening program.
Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition of the journal Mucosal Immunology from the Nature Publishing Group.
They've seen horrors, experienced constant threats and survived traumatic events. Canada's military personnel often come back home with memories they'd rather forget. It's not scientifically understood why some soldiers develop post-traumatic stress disorder (PTSD) while others don't. However, many veterans simply don't ask for psychological help.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela D Price, APRN-C 1301 W 12th Ave, Emporia, KS 66801-2587 Ph: (620) 343-2900 | Angela D Price, APRN-C 1301 W 12th Ave, Emporia, KS 66801-2587 Ph: (620) 343-2900 |
News Archive
News outlets report that the outcome of some states' gubernatorial races will likely change the outlook for the health overhaul's sweeping Medicaid expansion. In general, however, the future remains unsettled.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency for the EPA's ToxCast screening program.
Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition of the journal Mucosal Immunology from the Nature Publishing Group.
They've seen horrors, experienced constant threats and survived traumatic events. Canada's military personnel often come back home with memories they'd rather forget. It's not scientifically understood why some soldiers develop post-traumatic stress disorder (PTSD) while others don't. However, many veterans simply don't ask for psychological help.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 1 days ago
Janice M. Noyes, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 Commercial St, Emporia, KS 66801 Phone: 620-341-5223 Fax: 620-341-5045 | |
Renee Elaine Pankaskie, DNP-FNP, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1201 W 12th Ave, Emporia, KS 66801 Phone: 620-343-6800 | |
Mrs. Joan Priscilla Grother, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 W 12th Ave Ste 202, Emporia, KS 66801 Phone: 620-342-2900 | |
Adam Scott Galindo, AGACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 W 12th Ave, Emporia, KS 66801 Phone: 620-343-6800 | |
Opal Peggysue Fell, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 W 12th Ave, Ste 401, Emporia, KS 66801 Phone: 620-343-2900 Fax: 620-343-9484 | |
Tabatha K Morgan, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1301 W 12th Ave, Emporia, KS 66801 Phone: 620-342-2900 | |
Taryn Smith, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1000 Lincoln St, Emporia, KS 66801 Phone: 620-343-2211 Fax: 620-342-1021 |